Skip to main content
All evidence

Radiographic detection of post-traumatic bone fractures: contribution of artificial intelligence software to the analysis of senior and junior radiologists


The aims of this study were: (a) to evaluate the performance of an artificial intelligence (AI) software package (Boneview Trauma, Gleamer) for the detection of post-traumatic bone fractures in radiography as a standalone; (b) used by two radiologists (osteoarticular senior and junior); and (c) to determine to whom AI would be most helpful.


Within 14 days of a trauma, 101 consecutive patients underwent radiographic examination of the upper or lower limbs. The definite diagnosis for identifying fractures was: (a) radio-clinical consensus between the radiologist on-call who analyzed the images and the orthopedist (Group 1); (b) Cone Beam computed tomography (CBCT) exploration of the area of interest, in case of doubts or absence of consensus (Group 2). Independently of this diagnosis for both groups, the radiographic images were separately analyzed by two radiologists (osteoarticular senior: SR; junior: JR) prior without, and thereafter with the results of AI.


AI performed better than the radiologists in detecting common fractures (Group 1), but not subtle fractures (Group 2). In association with AI, both radiologists increased their overall performances in both groups, whereas this increase was significantly higher for the JR (p < 0.05).


AI is reliable for common radiographic fracture identification and is a useful learning tool for radiologists in training. However, the software’s overall performance does not exceed that of an osteoarticular senior radiologist, particularly in case of subtle lesions.


BoneView, our first clinical AI application, has become a global bone trauma X-ray interpretation standard, recognized for its scientific excellence. It pinpoints fractures, effusions, dislocations, and bone lesions efficiently. Recognized for its scientific rigor with publications in top-tier peer-reviewed journals, its clinical study won the prestigious 2022 Alexander Margulis Award for scientific excellence.

Learn more
Boneview V2